Identification of Long Non-Coding RNAs Deregulated in Multiple Myeloma Cells Resistant to Proteasome Inhibitors

While the clinical benefit of proteasome inhibitors (PIs) for multiple myeloma (MM) treatment remains unchallenged, dose-limiting toxicities and the inevitable emergence of drug resistance limit their long-term utility. Disease eradication is compromised by drug resistance that is either present de...

Descripción completa

Detalles Bibliográficos
Autores principales: Malek, Ehsan, Kim, Byung-Gyu, Driscoll, James J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5083923/
https://www.ncbi.nlm.nih.gov/pubmed/27782060
http://dx.doi.org/10.3390/genes7100084

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5083923/
https://www.ncbi.nlm.nih.gov/pubmed/27782060
http://dx.doi.org/10.3390/genes7100084

Ejemplares similares